Skip to content

Establishment and evaluation of clinical cohort follow-up system for hyperuricemia and primary gout

Establishment and evaluation of clinical cohort follow-up system for hyperuricemia and primary gout

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100043573
Enrollment
Unknown
Registered
2021-02-21
Start date
2021-03-01
Completion date
Unknown
Last updated
2021-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hyperuricemia and primary gout

Interventions

Case series:No

Sponsors

Affiliated Hospital of Qiingdao University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
6 Years to 86 Years

Inclusion criteria

Inclusion criteria: (1) Definite diagnosis of hyperuricemia (serum uric acid >= 416µmol/L (7mg/dL)) or primary gout (meets the 2015 ACR/EULAR classification and diagnostic criteria for gout); (2) Patients aged 6-86 years; (3) Patients who voluntarily participate in and sign informed consent.

Exclusion criteria

Exclusion criteria: (1) Patients with secondary gout (Gout Caused by potential diseases or drugs such as aspirin, cyclosporine, diuretics, etc.); (2) Pregnant or lactating women; (3) Patients with severe cardiovascular and cerebrovascular diseases, liver, kidney, malignant tumors, hematopoietic system and mental diseases. (4) Patients who voluntarily participate in and sign informed consent.

Design outcomes

Primary

MeasureTime frame
Serum uric acid;Metabolomics;

Secondary

MeasureTime frame
Blood routine;Blood biochemistry;Erythrocyte sedimentation rate;CRP;CA72-4;Urine routine;Urine PH;Ultrasound of urinary system;Joint ultrasound;Joint dual-energy CT;eGFR;The frequency of acute gout;Joint symptoms and signs;General symptoms and signs;Abdominal Doppler Ultrasound;ECG;Serum electrolytes;Tophi;Blood pressure;BMI;Waist circumference;Hips;Human leukocyte antigen B5801 gene detection;24-hour urine sample analysis;Joint X-ray;Stool routine;Intestinal flora detection;serum cytokines;cytokines in synovial fluid;Inbody body composition analysis;Quality of Life Assessment Scale;Vaccination against novel coronavirus (COVID-19);

Countries

China

Contacts

Public ContactJie Lu

Qingdao University

13127006046@163.com+86 17853297395

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 21, 2026